Fiserv FISV What Lies Ahead Fiserv posts 28 pct EPS beat exceeding estimates IPI Intrepid Potash posts 47 percent Q4 2025 EPS beat yet shares drop 134 percent in todays trading Vertex Pharmaceuticals VRTX Q1 2026 Earnings Preview Core Franchise Momentum and Pipeline Catalysts in Focus Valero Energy VLO Upgraded Earnings Forecasts and Refining Margin Strength Signal NearTerm Upside Amid Persistent LongTerm Risks Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside PEP PepsiCo notches 28 percent Q1 2026 EPS beat but stock falls 064 percent on mixed investor sentiment